Ledger.Open graph →
SEC Form D · filed April 11, 2016

Relieve Genetics, Inc

Offering
$17.3M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

David Mauney · San Francisco, CAExec · DirectorJose Haresco · San Francisco, CADirectorCraig R. Johnson · San Francisco, CAExec · DirectorH. T. Holt · Larkspur, CAExec · DirectorJacques J. Moye · Harmony, PAExec · DirectorAnthony J. Tomasello · Harmony, PADirectorShimon Erlichman · Charlotte, NCExec · DirectorMark Hughes · Denver, CODirectorDerek Pilling · Denver, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗